Impact of Uterine Closure Techniques on the Cesarean Scar Thickness After Repeated Cesarean Section

August 23, 2018 updated by: Ragıp Atakan Al, Ataturk University

Impact of Single Layer Versus Double Layer Uterine Closure on the Cesarean Scar Healing

We compares two techniques of uterine closure on myometrium thickness at the site of uterine scar of women who underwent repeated cesarean section. We will evaluate myometrial thickness by transvaginal ultrasound six months after cesarean.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

70

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Erzurum, Turkey, 25240
        • Recruiting
        • Atatürk Üniversitesi Araştırma Hastanesi
        • Contact:
          • Raşit Özler, Md

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 50 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • previous two or three cesarean
  • gestational weeks >=36 weeks

Exclusion Criteria:

  • risk of obstetric haemorrhage
  • suspicion or diagnosis placenta previa or accrete syndrome
  • chorioamnionitis
  • uterine myoma in the anterior uterine segment
  • hysterotomy other than lower segment uterine incision at previous cesarean

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Placebo Comparator: Single layer
Single layer closure
Uterine incision will be approximated with continuous unlocked suture avoiding the inclusion endometrium and without trimming incision edges.
Active Comparator: Double layer with resection
Double layer closure after resection uterine scar
Uterine incision will be trimmed and old scar tissue will be removed. Then first, endometrium will be approximated by continuous unlocked suture mimicking subcuticular suture avoiding the inclusion of endometrium and second, upper part of myometrium will be approximated by a continuous unlocked suture.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
residual myometrial thickness
Time Frame: 6 months after cesarean
Myometrial thickness at the uterine scar by transvaginal ultrasound
6 months after cesarean

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in hemoglobin
Time Frame: 48 hours after cesarean
Difference in haemoglobin measured preoperatively and postoperatively 48 hours
48 hours after cesarean
Length of hospitalization
Time Frame: One month after cesarean
Duration in days
One month after cesarean
residual myometrial thickness
Time Frame: 6 weeks after cesarean
Myometrial thickness at the uterine scar by transvaginal ultrasound
6 weeks after cesarean
Healing ratio
Time Frame: 6 months after cesarean
residual myometrial thickness * 100 /total myometrial thickness above uterine scar
6 months after cesarean
Healing ratio
Time Frame: 6 weeks after cesarean
residual myometrial thickness * 100 /total myometrial thickness above uterine scar
6 weeks after cesarean
Existence of cesarean scar defect
Time Frame: 6 months after cesarean
The presence or absence of a cesarean scar defect that was defined as any unechogenic area visualised by transvaginal ultrasound at the site of the cesarean scar with a depth of at least 1 mm.
6 months after cesarean
Existence of cesarean scar defect
Time Frame: 6 weeks after cesarean
The presence or absence of a cesarean scar defect that was defined as any unechogenic area visualised by transvaginal ultrasound at the site of the cesarean scar with a depth of at least 1 mm.
6 weeks after cesarean
Operation time
Time Frame: 10 minute after cesarean completed
skin-to-skin operation time
10 minute after cesarean completed
Blood product transfusion
Time Frame: One week after cesarean
unite number of transfused packed erythrocyte
One week after cesarean
Maternal infectious morbidity
Time Frame: six weeks after cesarean
prevalence of postpartum endometritis, skin wound dehiscence and post operative fever.
six weeks after cesarean

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 23, 2018

Primary Completion (Anticipated)

April 30, 2019

Study Completion (Anticipated)

April 30, 2019

Study Registration Dates

First Submitted

July 6, 2018

First Submitted That Met QC Criteria

August 21, 2018

First Posted (Actual)

August 23, 2018

Study Record Updates

Last Update Posted (Actual)

August 24, 2018

Last Update Submitted That Met QC Criteria

August 23, 2018

Last Verified

August 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • B.30.2.ATA.0.01.00/4

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cesarean Section Complications

Clinical Trials on Single layer closure

3
Subscribe